Literature DB >> 16382553

Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy.

Olivier Brugière1, Gaëlle Dauriat, Hervé Mal, Rolana Marrash-Chalha, Michel Fournier, Odile Groussard, Mathieu Besnard, Guy Lesèche, Bertrand Dupont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16382553

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

1.  In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest.

Authors:  Marta Torres-Narbona; Jesús Guinea; José Martínez-Alarcón; Teresa Peláez; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

Review 2.  Pulmonary Mucormycosis Over 130 Years: A Case Report and Literature Review.

Authors:  Hasan S Yamin; Amro Y Alastal; Izzedin Bakri
Journal:  Turk Thorac J       Date:  2017-01-01

Review 3.  Pharmacokinetic/pharmacodynamic profile of posaconazole.

Authors:  Yanjun Li; Ursula Theuretzbacher; Cornelius J Clancy; M Hong Nguyen; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

4.  A 29-year-old man with hospital-acquired cavitary pneumonia.

Authors:  Mansoor Mehmood; Ruba A Halloush; Faisal A Khasawneh
Journal:  Can Respir J       Date:  2014-04-07       Impact factor: 2.409

5.  Pulmonary mucormycosis: A case report and review of the literature.

Authors:  Xi-Ming Wang; Ling-Chuan Guo; Sheng-Li Xue; Yan-Bin Chen
Journal:  Oncol Lett       Date:  2016-03-22       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.